Can Investors Still Trust CannTrust? Pot Producer's Market Cap Has Plunged
Investing.com | Jul 16, 2019 04:56
What a difference a week makes in the marijuana trade – especially for investors of CannTrust Holdings (TSX:TRST), (NYSE:CTST). The Canadian cannabis producer’s stock rebounded Monday, gaining more than 19% on the day to close at US$3.055 (C$3.98) as it attempted to regain its footing after a disastrous five-day hemorrhage that saw it lose almost half its market cap.
The beleaguered marijuana manufacturer took a punishment beating last week, which began with a more-than-22% drop on Monday, after it publicly acknowledged that it had grown marijuana in five unlicensed rooms at its greenhouse facility in Pelham, Ont., between October 2018 and March 2019. The licences for that space were eventually obtained in April.
At first, the revelation of the unsanctioned growing rooms appeared as if it could simply have been a misunderstanding; possibly a miscommunication that led to the company jumping the gun by putting growing spaces into operation before the proper licenses had been secured. But by mid-week retailers in the provinces of Alberta and Ontario, Canada’s biggest pot market, had pulled CannTrust products from shelves after Health Canada, the federal legal marijuana regulator, put about 5,000 kilograms of the company’s dried cannabis on hold.
The pot producer then voluntarily put an additional 7,500 kilograms on hold. By Thursday, medical marijuana products that were believed to be linked to the unlicensed spaces were placed under quarantine by distributors in Denmark.
h2 And The Hits Were Still Coming.../h2A report in Canada’s largest national newspaper Friday struck another blow. Based on an interview with a former CannTrust employee, the company allegedly used “fake walls” in its greenhouse facility to hide the unlicensed cannabis plants to stage what were called “misleading photographs” submitted to Health Canada. The stock dropped another 17% to close Friday at US$2.565 (C$3.34).
By the time the week was over, CannTrust stock had lost a whopping 48% of its value, wiping US$174 million (C$228 million) from its market capitalization.
To compound the situation, the accusation of “misleading photographs” sparked a complaint to the Ontario Securities Exchange claiming the company put investors at risk by not disclosing it was in breach of regulations. The complaint hinges on whether the accusations made by the former employee constitute fraud.
Get The App
CannTrust stopped all sales and shipments of its products pending the Health Canada review, fueling speculation that this would deepen the chronic shortage of legal cannabis and drive prices up.
Losing Trust
As it appeared investors were losing their faith in CannTrust, industry observers were left wondering how much of the public’s belief in the burgeoning legal pot sector would be eroded along with it.
This week, the story takes a different turn. CannTrust appears to have regained its upward momentum. But will it be enough? Has anything really changed? Stay tuned. It’s only Tuesday.
h3 The Other Pot Stocks/h3As for the effect all this is having on the industry? All the major pot stocks were buoyed Monday:
- Cronos Group (TSX:CRON), (NASDAQ:CRON), was up 4.49% on the NASDAQ on the day and 4.86% on the S&P/TSX Composite
- Hexo (TSX:HEXO), (NYSE:HEXO) gained 4.12% in New York and 3.95% in Toronto
- Aurora Cannabis (TSX:ACB), (NYSE:ACB) jumped 3.4% in the U.S. and 3.63% in Canada
- Canopy Growth (TSX:WEED), (NYSE:CGC) added 2.63 on the New York Exchange and 2.78% on the TSX
- Tilray (NASDAQ:TLRY) gained 2.03%
- Aphria (TSX:APHA), (NYSE:APHA) added just under 1% on both sides of the border
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.